NCT07422623
Hallux Valgus Correction Surgery Recovery Using Semiconductor Embedded Therapeutic Sleeves
Enrolling by Invitation
NAAges 18–75InterventionalTreatmentINCREDIWEAR HOLDINGS, INC.
~115 participants
Updated 2026-05-22 on ClinicalTrials.gov
What's tested:Semiconductor embedded ankle sleeve and sockPlacebo ankle sleeve and sock
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in participant Foot and Ankle Outcome Score (FAOS)
Measured over 3 months
Conditions
Where it's being run
1 sites across 1 statesIowa1
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patients undergoing hallux valgus correction surgery including Lapiplasty Arthrodesis, MTP fusion, and TMT+MTP arthrodesis (double first ray arthrodesis).
Patients aged 18-75
Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.
Patients who are willing and able to sign corresponding research subject consent form.
Exclusion
Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease
Patient has severe medical condition, including recent myocardial infarction, unstable angina, heart failure, severe anemia
Patient has had prior surgical treatment of the foot within the last 5 years
Patient has external hardware (wires) protruding from the foot post-surgery
Patient has had prior injections (PRP or Stem Cell) in the foot within the last 1 year
Patient has rheumatoid arthritis
Patient has chronic pain conditions unrelated to foot condition
Patient has auto-immune or auto-inflammatory diseases
Patient has used tobacco within the last 90 days
Patient has poorly controlled diabetes as determined by A1C levels \> 7.0
Patient has an active infection (local or systemic)
Patient is unwilling or unable to sign the corresponding research subject consent form
Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.
What this trial measures
- Change in participant Foot and Ankle Outcome Score (FAOS)3 months
Changes in participant function and pain as determined by the Foot and Ankle Outcome score (FAOS) FAOS: Lowest score: 0 (extreme symptoms/limiations) Highest score: 100 (no symptoms or limitations)